**Patient Discharge Summary**

**Patient Information:**

* Name: John Doe
* Date of Birth: March 12, 1975
* Medical Record Number: 123456
* Admitting Diagnosis: Type 2 Diabetes

**Admission and Diagnostic Work-up:**

John Doe, a 47-year-old male, was admitted to the endocrinology unit on March 10, 2023, with a chief complaint of increased thirst and urination over the past few weeks. On admission, his fasting plasma glucose (FPG) level was 240 mg/dL (> 11.1 mmol/L), and his glycosylated hemoglobin (HbA1C) level was 8.2%. The patient was diagnosed with type 2 diabetes based on these laboratory results.

**Diagnostic Tests and Procedures:**

During his hospital stay, Mr. Doe underwent the following diagnostic tests and procedures:

* FPG and HbA1C testing
* Oral glucose tolerance testing (OGTT)
* Foot and funduscopic examinations
* Urine testing for albuminuria
* Measurement of serum creatinine and lipid profile

**Treatment and Management:**

Mr. Doe was treated with a combination of diet, exercise, patient education, and medications. His treatment plan included:

* Metformin 1000 mg twice daily for type 2 diabetes
* Insulin glargine 10 units at bedtime for insulin therapy
* Semaglutide 2.4 mg once weekly for weight loss and glycemic control
* Dietary recommendations focused on whole foods and high-quality carbohydrates, individualized to accommodate his comorbid conditions

**Patient Education:**

Mr. Doe received extensive patient education on the causes of diabetes, symptoms and signs of hypoglycemia, hyperglycemia, and diabetic complications. He was also educated on adjusting insulin doses based on blood glucose levels and carbohydrate intake. The patient was instructed to monitor his blood glucose levels regularly and adjust his insulin doses accordingly.

**Physical Activity:**

Mr. Doe was instructed to engage in at least 150 minutes of moderate-intensity aerobic exercise per week, with adjustments for hypoglycemia risk. He was also advised to incorporate resistance exercise into his routine.

**Follow-up Care:**

Mr. Doe was discharged from the hospital on March 15, 2023, with a follow-up appointment scheduled for April 5, 2023. He was instructed to return to the hospital if he experienced any worsening symptoms or complications.

**Discharge Instructions:**

Mr. Doe was given the following discharge instructions:

* Continue metformin 1000 mg twice daily
* Continue insulin glargine 10 units at bedtime
* Continue semaglutide 2.4 mg once weekly
* Monitor blood glucose levels regularly and adjust insulin doses accordingly
* Engage in at least 150 minutes of moderate-intensity aerobic exercise per week
* Incorporate resistance exercise into his routine
* Follow up with his primary care physician in one month for further evaluation and management

**Next Steps:**

Mr. Doe's treatment plan will be continued as outpatient, with regular follow-up appointments to monitor his progress and adjust his treatment plan as needed. He will also receive regular professional podiatric care to address any potential foot complications.

**Additional Recommendations:**

Mr. Doe was also recommended to receive vaccinations against Streptococcus pneumoniae, influenza virus, hepatitis B, varicella, and SARS-CoV-2.

**Conclusion:**

Mr. Doe was discharged from the hospital with a comprehensive treatment plan for type 2 diabetes. He will require ongoing follow-up care and management to achieve optimal glycemic control and prevent complications.